• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用闪烁纳米管无创治疗老年痴呆症。

Noninvasive Treatment of Alzheimer's Disease with Scintillating Nanotubes.

机构信息

Department of Chemistry, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Department of Materials Science, University of Milano-Bicocca, Via R. Cozzi 55, Milan, 20125, Italy.

出版信息

Adv Healthc Mater. 2023 Dec;12(32):e2301527. doi: 10.1002/adhm.202301527. Epub 2023 Nov 3.

DOI:10.1002/adhm.202301527
PMID:37826854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11469333/
Abstract

Effective and accessible treatments for Alzheimer's disease (AD) are urgently needed. Soluble Aβ oligomers are identified as neurotoxic species in AD and targeted in antibody-based drug development to mitigate cognitive decline. However, controversy exists concerning their efficacy and safety. In this study, an alternative strategy is proposed to inhibit the formation of Aβ oligomers by selectively oxidizing specific amino acids in the Aβ sequence, thereby preventing its aggregation. Targeted oxidation is achieved using biocompatible and blood-brain barrier-permeable multicomponent nanoscintillators that generate singlet oxygen upon X-ray interaction. Surface-modified scintillators interact selectively with Aβ and, upon X-ray irradiation, inhibit the formation of neurotoxic aggregates both in vitro and in vivo. Feeding transgenic Caenorhabditis elegans expressing human Aβ with the nanoscintillators and subsequent irradiation with soft X-ray reduces Aβ oligomer levels, extends lifespan, and restores memory and behavioral deficits. These findings support the potential of X-ray-based therapy for AD and warrant further development.

摘要

治疗阿尔茨海默病(AD)的有效且易于获得的方法亟待开发。可溶的 Aβ 寡聚体被鉴定为 AD 中的神经毒性物质,并成为基于抗体的药物开发的靶点,以减轻认知能力下降。然而,其疗效和安全性仍存在争议。在这项研究中,提出了一种替代策略,通过选择性氧化 Aβ 序列中的特定氨基酸来抑制 Aβ 寡聚体的形成,从而阻止其聚集。靶向氧化是通过使用生物相容性和血脑屏障可渗透的多组分纳米闪烁体来实现的,当与 X 射线相互作用时,纳米闪烁体可产生单线态氧。经过表面修饰的纳米闪烁体能与 Aβ 选择性相互作用,在 X 射线照射下,可在体外和体内抑制神经毒性聚集物的形成。用纳米闪烁体喂养表达人 Aβ 的转基因秀丽隐杆线虫,并随后用软 X 射线照射,可降低 Aβ 寡聚体水平,延长寿命,并恢复记忆和行为缺陷。这些发现支持了基于 X 射线的 AD 治疗的潜力,并需要进一步开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a14/11469333/a9d1b63a5fb5/ADHM-12-2301527-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a14/11469333/82505a5903a5/ADHM-12-2301527-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a14/11469333/468342bb8c01/ADHM-12-2301527-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a14/11469333/d27c7e6b6060/ADHM-12-2301527-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a14/11469333/a9d1b63a5fb5/ADHM-12-2301527-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a14/11469333/82505a5903a5/ADHM-12-2301527-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a14/11469333/468342bb8c01/ADHM-12-2301527-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a14/11469333/d27c7e6b6060/ADHM-12-2301527-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a14/11469333/a9d1b63a5fb5/ADHM-12-2301527-g005.jpg

相似文献

1
Noninvasive Treatment of Alzheimer's Disease with Scintillating Nanotubes.用闪烁纳米管无创治疗老年痴呆症。
Adv Healthc Mater. 2023 Dec;12(32):e2301527. doi: 10.1002/adhm.202301527. Epub 2023 Nov 3.
2
The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.正在寻找小分子以研究阿尔茨海默病中与金属相关的淀粉样-β 物种。
Acc Chem Res. 2014 Aug 19;47(8):2475-82. doi: 10.1021/ar500152x. Epub 2014 Jul 31.
3
Early diagnosis and treatment of Alzheimer's disease by targeting toxic soluble Aβ oligomers.通过靶向毒性可溶性 Aβ 寡聚体实现阿尔茨海默病的早期诊断和治疗。
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2210766119. doi: 10.1073/pnas.2210766119. Epub 2022 Nov 28.
4
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.靶向淀粉样β-蛋白1-42寡聚体的阿尔茨海默病治疗方法I:药物候选物可取代与特定神经元受体结合的β-淀粉样蛋白42寡聚体,从而改善认知缺陷。
PLoS One. 2014 Nov 12;9(11):e111898. doi: 10.1371/journal.pone.0111898. eCollection 2014.
5
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.靶向淀粉样β1-42寡聚体的阿尔茨海默病治疗方法II:Sigma-2/PGRMC1受体介导β淀粉样蛋白42寡聚体的结合和突触毒性。
PLoS One. 2014 Nov 12;9(11):e111899. doi: 10.1371/journal.pone.0111899. eCollection 2014.
6
Multifunctional Liposomes Targeting Amyloid-β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease.靶向淀粉样β寡聚体的多功能脂质体用于阿尔茨海默病的早期诊断和治疗。
Small. 2024 Aug;20(31):e2311670. doi: 10.1002/smll.202311670. Epub 2024 Mar 10.
7
Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.萘醌-色氨酸可降低阿尔茨海默病动物模型中的神经毒性 Aβ*56 水平并改善认知功能。
Neurobiol Dis. 2012 Jun;46(3):663-72. doi: 10.1016/j.nbd.2012.03.005. Epub 2012 Mar 19.
8
Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease.无毒Aβ寡聚体的稳定化:对羟基喹啉在阿尔茨海默病中作用机制的见解。
J Neurosci. 2015 Feb 18;35(7):2871-84. doi: 10.1523/JNEUROSCI.2912-14.2015.
9
Peripheral administration of nanomicelle-encapsulated anti-Aβ oligomer fragment antibody reduces various toxic Aβ species in the brain.外周给予载药纳米胶束的抗 Aβ 寡聚体片段抗体可减少脑内各种毒性 Aβ 物质。
J Nanobiotechnology. 2023 Jan 31;21(1):36. doi: 10.1186/s12951-023-01772-y.
10
α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.淀粉样 β 肽中的 α-折叠二级结构驱动阿尔茨海默病中的聚集和毒性。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8895-8900. doi: 10.1073/pnas.1820585116. Epub 2019 Apr 19.

引用本文的文献

1
The role of energy deposition on the luminescence sensitization in porphyrin-functionalized SiO/ZnO nanoparticles under X-ray excitation.X射线激发下能量沉积对卟啉功能化SiO/ZnO纳米颗粒发光敏化的作用。
Nanoscale Adv. 2025 Jan 8;7(5):1464-1474. doi: 10.1039/d4na00640b. eCollection 2025 Feb 25.
2
Toward "super-scintillation" with nanomaterials and nanophotonics.迈向基于纳米材料和纳米光子学的“超级闪烁”
Nanophotonics. 2024 Apr 15;13(11):1953-1962. doi: 10.1515/nanoph-2023-0946. eCollection 2024 May.

本文引用的文献

1
Drug trial for Alzheimer's disease is a game changer.阿尔茨海默病药物试验是一个改变局面的因素。
Nature. 2023 Mar;615(7950):42-43. doi: 10.1038/d41586-023-00393-7.
2
Aza-Residue Modulation of Cyclic d,l-α-Peptide Nanotube Assembly with Enhanced Anti-Amyloidogenic Activity.氮杂残基调控环二肽纳米管组装增强抗淀粉样蛋白活性。
J Med Chem. 2023 Feb 23;66(4):3058-3072. doi: 10.1021/acs.jmedchem.2c02049. Epub 2023 Feb 10.
3
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
4
Early diagnosis and treatment of Alzheimer's disease by targeting toxic soluble Aβ oligomers.通过靶向毒性可溶性 Aβ 寡聚体实现阿尔茨海默病的早期诊断和治疗。
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2210766119. doi: 10.1073/pnas.2210766119. Epub 2022 Nov 28.
5
Design Principles of Hybrid Nanomaterials for Radiotherapy Enhanced by Photodynamic Therapy.杂化纳米材料用于光动力疗法增强放射治疗的设计原则。
Int J Mol Sci. 2022 Aug 5;23(15):8736. doi: 10.3390/ijms23158736.
6
Controlled and Selective Photo-oxidation of Amyloid-β Fibrils by Oligomeric -Phenylene Ethynylenes.寡聚苯乙炔对淀粉样β纤维的可控选择性光氧化。
ACS Appl Mater Interfaces. 2022 Apr 6;14(13):14871-14886. doi: 10.1021/acsami.1c22869. Epub 2022 Mar 28.
7
Functionalized Scintillating Nanotubes for Simultaneous Radio- and Photodynamic Therapy of Cancer.功能化闪烁纳米管用于癌症的放化疗联合治疗。
ACS Appl Mater Interfaces. 2021 Mar 24;13(11):12997-13008. doi: 10.1021/acsami.1c02504. Epub 2021 Mar 15.
8
Alzheimer's Therapeutic Strategy: Photoactive Platforms for Suppressing the Aggregation of Amyloid β Protein.阿尔茨海默病治疗策略:用于抑制淀粉样β蛋白聚集的光活性平台
Front Chem. 2020 Jul 21;8:509. doi: 10.3389/fchem.2020.00509. eCollection 2020.
9
Native Ion Mobility-Mass Spectrometry Reveals the Formation of β-Barrel Shaped Amyloid-β Hexamers in a Membrane-Mimicking Environment.天然离子淌度-质谱揭示了在模拟膜环境中β-桶状淀粉样β六聚体的形成。
J Am Chem Soc. 2019 Jul 3;141(26):10440-10450. doi: 10.1021/jacs.9b04596. Epub 2019 Jun 19.
10
α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.淀粉样 β 肽中的 α-折叠二级结构驱动阿尔茨海默病中的聚集和毒性。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8895-8900. doi: 10.1073/pnas.1820585116. Epub 2019 Apr 19.